Notebook

At its members' meeting on April 13 in Research Triangle Park, N.C., the Association of Biotechnology Companies (ABC) voted unanimously to merge with the Industrial Biotechnology Association (IBA), forming a new group called the Biotechnology Industry Organization (BIO). The merger becomes official July 1. IBA members had also unanimously endorsed the merger at their meeting in February (Notebook, The Scientist, March 8, 1993, page 4). "I expected a strong vote, but I never expected unanim

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

At its members' meeting on April 13 in Research Triangle Park, N.C., the Association of Biotechnology Companies (ABC) voted unanimously to merge with the Industrial Biotechnology Association (IBA), forming a new group called the Biotechnology Industry Organization (BIO). The merger becomes official July 1. IBA members had also unanimously endorsed the merger at their meeting in February (Notebook, The Scientist, March 8, 1993, page 4). "I expected a strong vote, but I never expected unanimity," says BIO president Carl Feldbaum. "This gives us enormous momentum in getting the merger done and moving forward as one unified organization." Though the two groups had held opposing positions on several matters (Barbara Spector, The Scientist, Feb. 22, 1993, page 1), Feldbaum says, "We've resolved 99 percent of the issues that had divided the two organizations."

Another topic near and dear to the hearts of ABC constituents-- financing--was addressed at the meeting as participants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies